Editorial: The ever-changing scenario of first line treatment of metastatic renal cell carcinoma
Main Authors: | Maria Giuseppa Vitale, Marco Maruzzo, Roberto Sabbatini |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1183749/full |
Similar Items
-
Experience of Sorafenib as First-Line Treatment in Metastatic Renal Cell Carcinoma in a Tertiary Care Centre
by: Mohit Saxena, et al.
Published: (2018-07-01) -
Cabozantinib real‐world effectiveness in the first‐through fourth‐line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
by: Chun Loo Gan, et al.
Published: (2021-02-01) -
Grading Challenges and Prognostic Insights in Chromophobe Renal Cell Carcinoma: A Retrospective Study of 72 Patients
by: Dimitrios Papanikolaou, et al.
Published: (2024-06-01) -
Metastatic renal cell carcinoma, the possibility of targeted therapy. Case.
by: K. V. Menshikov, et al.
Published: (2021-12-01) -
The Effect of Cytoreductive Partial Nephrectomy in Elderly Patients with Metastatic Renal Cell Carcinoma
by: Chen J, et al.
Published: (2020-03-01)